On the face of it, this might sound a bit odd.
But then, that’s the way politics and foreign policy often sound. Odd.
The U.S., which pays for something like 70 percent of the costs of researching and developing new drugs, this week at the World Health Assembly meeting in Geneva opposed creating a mechanism requiring other nations to pay more — a fair share.
In short, the Obama Administration opposed a plan to reduce our disproportionate spending on drug development.